Artificial Intelligence and Simulation-Based Learning in Pharmacy: Current Trends, Educational Outcomes, and Future Perspectives
AISIM26 Sağlık Profesyonellerinin Eğitiminde Yapay Zeka ve Simülasyon Kongresi, Trabzon, Türkiye, 4 - 07 Haziran 2026, ss.54, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Basıldığı Şehir: Trabzon
- Basıldığı Ülke: Türkiye
- Sayfa Sayıları: ss.54
- Karadeniz Teknik Üniversitesi Adresli: Evet
Özet
Pharmacy education and pharmaceutical sciences have entered a profound transformation
period driven by digital transformation and artificial intelligence (Kavitkar et al., 2026; Phade
et al., 2026). Given that pharmaceutical technology requires high-cost, regulated laboratory
processes to convert theoretical knowledge into practical skills, this study systematically
reviews the integration of artificial intelligence and simulation technologies within pharmacy
curricula, cleanroom practices, and formulation development. Through a comprehensive
literature search (2019-2025) focusing on virtual reality-supported laboratory applications,
virtual patient simulations, and "in silico" modeling for drug formulation, it was found that
simulation technologies create a "safe-to-fail" environment that significantly enhances student
competency. Specifically, VR cleanroom simulations developed for USP 797/GMP standards
markedly improve students' knowledge and self-confidence in sterile preparation (AlMuzaini
et al., 2023). Virtual prescription dispensing and pharmacology simulation systems have proven
more effective than traditional methods in developing clinical decision-making skills
(Mohammed et al., 2026; Zheng et al., 2025). In pharmaceutical technology R&D, Finite
Element Analysis and Machine Learning algorithms have demonstrated a 20-30% reduction in
time and cost by optimizing formulation parameters, such as 3D printing features and drug
release kinetics (Abdullah et al., 2024; Sarabi et al., 2022; Yan et al., 2022). Furthermore, AI
optimizes student performance through personalized learning pathways and predictive analytics
(B et al., 2026; Phade et al., 2026). These technologies have evolved from supplementary
resources into a fundamental paradigm in pharmacy education and drug technology (Kavitkar,
Supalkar, A., et al., 2026; Kavitkar, Supalkar, Pachghare, et al., 2026). Integrating these tools
into the curriculum ensures standardization and safety while preparing students for the modern
pharmaceutical industry (Phade et al., 2026; Yang et al., 2023). Future perspectives suggest that
AI-based decision-making systems will become integral to clinical pharmacy practice, while in
silico simulations will dominate drug development processes.